PINK:NYE-Simplify Exchange Traded Funds - Simplify Health Care ETF (USD)

ETF | Others |

Last Closing

USD 28.71

Change

-0.09 (-0.31)%

Market Cap

USD 0.13B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.23 (+1.19%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.19 (+0.34%)

USD 32.43B
DTB DTB

-0.01 (-0.05%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

+0.30 (+0.99%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

+2.22 (+4.38%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

+0.03 (+0.06%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

+0.04 (+0.04%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

+1.57 (+1.78%)

USD 10.49B
DFUV Dimensional US Marketwide Valu..

+0.24 (+0.62%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

+0.75 (+1.46%)

USD 9.40B

ETFs Containing PINK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.01% 85% B 76% C+
Dividend Return 0.11% 5% F 4% F
Total Return 5.12% 83% B 73% C
Trailing 12 Months  
Capital Gain 10.40% 63% D 64% D
Dividend Return 1.04% 17% F 12% F
Total Return 11.44% 61% D- 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.92% 64% D 49% F
Dividend Return 2.20% 58% F 39% F
Total Return 0.28% 19% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 6.93% 65% D 88% B+
Risk Adjusted Return 31.74% 58% F 55% F
Market Capitalization 0.13B 68% D+ 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.